275 related articles for article (PubMed ID: 37582401)
1. Research Progress on the Role and Mechanism of IL-37 in Liver Diseases.
Jiang B; Zhou Y; Liu Y; He S; Liao B; Peng T; Yao L; Qi L
Semin Liver Dis; 2023 Aug; 43(3):336-350. PubMed ID: 37582401
[TBL] [Abstract][Full Text] [Related]
2. Exogenous interleukin-33 promotes hepatocellular carcinoma growth by remodelling the tumour microenvironment.
Wang W; Wu J; Ji M; Wu C
J Transl Med; 2020 Dec; 18(1):477. PubMed ID: 33308251
[TBL] [Abstract][Full Text] [Related]
3. Expression of pro- and anti-inflammatory cytokines in relation to apoptotic genes in Egyptian liver disease patients associated with HCV-genotype-4.
Zekri AR; Bahnassy AA; Abdel-Wahab SA; Khafagy MM; Loutfy SA; Radwan H; Shaarawy SM
J Gastroenterol Hepatol; 2009 Mar; 24(3):416-28. PubMed ID: 19054267
[TBL] [Abstract][Full Text] [Related]
4. IL-23 production of liver inflammatory macrophages to damaged hepatocytes promotes hepatocellular carcinoma development after chronic hepatitis B virus infection.
Zang M; Li Y; He H; Ding H; Chen K; Du J; Chen T; Wu Z; Liu H; Wang D; Cai J; Qu C
Biochim Biophys Acta Mol Basis Dis; 2018 Dec; 1864(12):3759-3770. PubMed ID: 30292634
[TBL] [Abstract][Full Text] [Related]
5. Change in inflammatory cytokine profiles after transarterial chemotherapy in patients with hepatocellular carcinoma.
Kim MJ; Jang JW; Oh BS; Kwon JH; Chung KW; Jung HS; Jekarl DW; Lee S
Cytokine; 2013 Nov; 64(2):516-22. PubMed ID: 24035756
[TBL] [Abstract][Full Text] [Related]
6. Study on the anti-tumor mechanism related to immune microenvironment of Bombyx Batryticatus on viral and non-viral infections of hepatocellular carcinoma.
Yuan L; Bing Z; Han J; An X; Liu X; Li R; Wang C; Sun X; Yang L; Yang K
Biomed Pharmacother; 2020 Apr; 124():109838. PubMed ID: 31981943
[TBL] [Abstract][Full Text] [Related]
7. Bone morphogenetic protein 4 provides cancer-supportive phenotypes to liver fibroblasts in patients with hepatocellular carcinoma.
Mano Y; Yoshio S; Shoji H; Tomonari S; Aoki Y; Aoyanagi N; Okamoto T; Matsuura Y; Osawa Y; Kimura K; Yugawa K; Wang H; Oda Y; Yoshizumi T; Maehara Y; Kanto T
J Gastroenterol; 2019 Nov; 54(11):1007-1018. PubMed ID: 30941514
[TBL] [Abstract][Full Text] [Related]
8. TANK-Binding Kinase 1 (TBK1) Serves as a Potential Target for Hepatocellular Carcinoma by Enhancing Tumor Immune Infiltration.
Jiang Y; Chen S; Li Q; Liang J; Lin W; Li J; Liu Z; Wen M; Cao M; Hong J
Front Immunol; 2021; 12():612139. PubMed ID: 33679751
[TBL] [Abstract][Full Text] [Related]
9. Viral Hepatitides, Inflammation and Tumour Microenvironment.
Timperi E; Barnaba V
Adv Exp Med Biol; 2020; 1263():25-43. PubMed ID: 32588321
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-35 has a tumor-promoting role in hepatocellular carcinoma.
Liu X; Ren H; Guo H; Wang W; Zhao N
Clin Exp Immunol; 2021 Feb; 203(2):219-229. PubMed ID: 33030251
[TBL] [Abstract][Full Text] [Related]
11. The tumor microenvironment in hepatocellular carcinoma (review).
Leonardi GC; Candido S; Cervello M; Nicolosi D; Raiti F; Travali S; Spandidos DA; Libra M
Int J Oncol; 2012 Jun; 40(6):1733-47. PubMed ID: 22447316
[TBL] [Abstract][Full Text] [Related]
12. An Immune Gene Expression Signature Associated With Development of Human Hepatocellular Carcinoma Identifies Mice That Respond to Chemopreventive Agents.
Moeini A; Torrecilla S; Tovar V; Montironi C; Andreu-Oller C; Peix J; Higuera M; Pfister D; Ramadori P; Pinyol R; Solé M; Heikenwälder M; Friedman SL; Sia D; Llovet JM
Gastroenterology; 2019 Nov; 157(5):1383-1397.e11. PubMed ID: 31344396
[TBL] [Abstract][Full Text] [Related]
13. Liver-infiltrating CD8(+) lymphocytes as prognostic factor for tumour recurrence in hepatitis C virus-related hepatocellular carcinoma.
Ramzan M; Sturm N; Decaens T; Bioulac-Sage P; Bancel B; Merle P; Tran Van Nhieu J; Slama R; Letoublon C; Zarski JP; Jouvin-Marche E; Marche PN; Leroy V
Liver Int; 2016 Mar; 36(3):434-44. PubMed ID: 26215124
[TBL] [Abstract][Full Text] [Related]
14. New LncRNAs in Chronic Hepatitis C progression: from fibrosis to hepatocellular carcinoma.
Ferrasi AC; Fernandez GJ; Grotto RMT; Silva GF; Goncalves J; Costa MC; Enguita FJ; Pardini MIMC
Sci Rep; 2020 Jun; 10(1):9886. PubMed ID: 32555359
[TBL] [Abstract][Full Text] [Related]
15. Icaritin-induced immunomodulatory efficacy in advanced hepatitis B virus-related hepatocellular carcinoma: Immunodynamic biomarkers and overall survival.
Qin SK; Li Q; Ming Xu J; Liang J; Cheng Y; Fan Y; Jiang J; Ye H; Tao H; Li L; Zheng L; Wei Z; Li S; Meng K; Ye B; Sun Y
Cancer Sci; 2020 Nov; 111(11):4218-4231. PubMed ID: 32889778
[TBL] [Abstract][Full Text] [Related]
16. IL-6 and PD-L1 blockade combination inhibits hepatocellular carcinoma cancer development in mouse model.
Liu H; Shen J; Lu K
Biochem Biophys Res Commun; 2017 Apr; 486(2):239-244. PubMed ID: 28254435
[TBL] [Abstract][Full Text] [Related]
17. Inflammatory microenvironment of fibrotic liver promotes hepatocellular carcinoma growth, metastasis and sorafenib resistance through STAT3 activation.
Jiang Y; Chen P; Hu K; Dai G; Li J; Zheng D; Yuan H; He L; Xie P; Tu M; Peng S; Qu C; Lin W; Chung RT; Hong J
J Cell Mol Med; 2021 Feb; 25(3):1568-1582. PubMed ID: 33410581
[TBL] [Abstract][Full Text] [Related]
18. CCN: core regulatory proteins in the microenvironment that affect the metastasis of hepatocellular carcinoma?
Jia Q; Dong Q; Qin L
Oncotarget; 2016 Jan; 7(2):1203-14. PubMed ID: 26497214
[TBL] [Abstract][Full Text] [Related]
19. Protein phosphatases regulate the liver microenvironment in the development of hepatocellular carcinoma.
Yoon JS; Lee CW
Exp Mol Med; 2022 Nov; 54(11):1799-1813. PubMed ID: 36380016
[TBL] [Abstract][Full Text] [Related]
20. Hypoxia-induced myeloid derived growth factor promotes hepatocellular carcinoma progression through remodeling tumor microenvironment.
Wang X; Mao J; Zhou T; Chen X; Tu H; Ma J; Li Y; Ding Y; Yang Y; Wu H; Tang X
Theranostics; 2021; 11(1):209-221. PubMed ID: 33391471
[No Abstract] [Full Text] [Related]
[Next] [New Search]
